Literature DB >> 16517593

Interaction of lipoprotein lipase and receptor-associated protein.

Shallee Page1, Andrea Judson, Kristan Melford, André Bensadoun.   

Abstract

Receptor-associated protein (RAP) is a recognized chaperone/escort protein for members of the low density lipoprotein receptor family. In this report, we show that RAP binds to lipoprotein lipase (LPL) and may play a role in the maturation of LPL. Binding of highly purified RAP to LPL was demonstrated in vitro by solid phase assays, surface plasmon resonance, and rate zonal centrifugation. The dissociation constant for this interaction measured by the first two techniques ranged between 2.4 and 13 nM, values similar to those reported for the binding of RAP to LRP or gp330. The specificity of the interaction was demonstrated by competition with a panel of LPL monoclonal antibodies. Rate zonal centrifugation demonstrated the presence of a stable complex with an apparent Mr consistent with the formation of a complex between monomeric LPL and RAP. RAP x LPL complexes were co-immunoprecipitated in adipocyte lysates or from solutions of purified LPL and RAP. The interaction was also demonstrated in whole cells by cross-linking experiments. RAP-deficient adipocytes secreted LPL with a specific activity 2.5-fold lower than the lipase secreted by control cells. Heparin addition to cultured RAP-deficient adipocytes failed to stimulate LPL secretion in the medium, suggesting defective binding of the lipase to the plasma membrane. These studies demonstrate that RAP binds to LPL with high affinity both in purified systems and cell extracts and that RAP-deficient adipocytes secrete poorly assembled LPL. A function of RAP may be to prevent premature interaction of LPL with binding partners in the secretory pathway, namely LRP and heparan sulfate proteoglycan.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517593     DOI: 10.1074/jbc.M600995200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Mutating a conserved cysteine in GPIHBP1 reduces amounts of GPIHBP1 in capillaries and abolishes LPL binding.

Authors:  Christopher M Allan; Cris J Jung; Mikael Larsson; Patrick J Heizer; Yiping Tu; Norma P Sandoval; Tiffany Ly P Dang; Rachel S Jung; Anne P Beigneux; Pieter J de Jong; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2017-05-05       Impact factor: 5.922

2.  Mobility of "HSPG-bound" LPL explains how LPL is able to reach GPIHBP1 on capillaries.

Authors:  Christopher M Allan; Mikael Larsson; Rachel S Jung; Michael Ploug; André Bensadoun; Anne P Beigneux; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2016-11-03       Impact factor: 5.922

3.  Deficiency of receptor-associated protein attenuates angiotensin II-induced atherosclerosis in hypercholesterolemic mice without influencing abdominal aortic aneurysms.

Authors:  Shaoping Wang; Venkateswaran Subramanian; Hong Lu; Deborah A Howatt; Jessica J Moorleghen; Richard Charnigo; Lisa A Cassis; Alan Daugherty
Journal:  Atherosclerosis       Date:  2011-11-19       Impact factor: 5.162

4.  Low and high affinity receptors mediate cellular uptake of heparanase.

Authors:  Olga Ben-Zaken; Itay Shafat; Svetlana Gingis-Velitski; Haim Bangio; Idil Kasuto Kelson; Tal Alergand; Yehudit Amor; Ruth Ben-Yakar Maya; Israel Vlodavsky; Neta Ilan
Journal:  Int J Biochem Cell Biol       Date:  2007-09-29       Impact factor: 5.085

5.  Assessing mechanisms of GPIHBP1 and lipoprotein lipase movement across endothelial cells.

Authors:  Brandon S J Davies; Chris N Goulbourne; Richard H Barnes; Kirsten A Turlo; Peter Gin; Sue Vaughan; David J Vaux; André Bensadoun; Anne P Beigneux; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2012-09-24       Impact factor: 5.922

6.  Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice.

Authors:  Michael M Weinstein; Liya Yin; Anne P Beigneux; Brandon S J Davies; Peter Gin; Kristine Estrada; Kristan Melford; Joseph R Bishop; Jeffrey D Esko; Geesje M Dallinga-Thie; Loren G Fong; André Bensadoun; Stephen G Young
Journal:  J Biol Chem       Date:  2008-10-08       Impact factor: 5.157

7.  An upstream enhancer regulates Gpihbp1 expression in a tissue-specific manner.

Authors:  Christopher M Allan; Patrick J Heizer; Yiping Tu; Norma P Sandoval; Rachel S Jung; Jazmin E Morales; Eniko Sajti; Ty D Troutman; Thomas L Saunders; Darren A Cusanovich; Anne P Beigneux; Casey E Romanoski; Loren G Fong; Stephen G Young
Journal:  J Lipid Res       Date:  2018-12-31       Impact factor: 5.922

8.  Apolipoprotein C-III inhibits triglyceride hydrolysis by GPIHBP1-bound LPL.

Authors:  Mikael Larsson; Christopher M Allan; Rachel S Jung; Patrick J Heizer; Anne P Beigneux; Stephen G Young; Loren G Fong
Journal:  J Lipid Res       Date:  2017-07-10       Impact factor: 5.922

9.  Deletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humans.

Authors:  Joseph R Bishop; Maria Rita Passos-Bueno; Loren Fong; Kristin I Stanford; Jon C Gonzales; Erika Yeh; Stephen G Young; Andre Bensadoun; Joseph L Witztum; Jeffrey D Esko; Karen S Moulton
Journal:  PLoS One       Date:  2010-11-10       Impact factor: 3.240

10.  Novel associations of nonstructural Loci with paraoxonase activity.

Authors:  Ellen E Quillen; David L Rainwater; Thomas D Dyer; Melanie A Carless; Joanne E Curran; Matthew P Johnson; Harald H H Göring; Shelley A Cole; Sue Rutherford; Jean W Maccluer; Eric K Moses; John Blangero; Laura Almasy; Michael C Mahaney
Journal:  J Lipids       Date:  2012-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.